Conmed (CNMD) Cash from Operations Growth (5y) (2015 - 2026)
Powered by 
Analysis
Conmed (CNMD) Cash from Operations Growth (5y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn |
| 10 | Conmed | 1.48 Bn | 1.44 Bn | 197.46 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.59% |
| Mar 31, 2026 | -9.62% |
| Dec 31, 2025 | 18.13% |
| Sep 30, 2025 | 8.85% |
| Jun 30, 2025 | 39.38% |
| Mar 31, 2025 | 62.01% |
| Dec 31, 2024 | 1.18% |
| Sep 30, 2024 | 6.95% |
| Jun 30, 2024 | 14.95% |
| Mar 31, 2024 | 56.64% |
| Dec 31, 2023 | 17.95% |
| Sep 30, 2023 | 60.35% |
| Jun 30, 2023 | 5.28% |
| Mar 31, 2023 | -16.58% |
| Dec 31, 2022 | -20.66% |
| Sep 30, 2022 | 14.03% |
| Jun 30, 2022 | 3.18% |
| Mar 31, 2022 | -53.63% |
| Dec 31, 2021 | 19.80% |
| Sep 30, 2021 | -2.91% |